Rosetta Genomics Company Description
Rosetta Genomics is dedicated to unlocking the secrets of microRNAs. Building on the work of the Human Genome Project, Rosetta Genomics has focused its efforts on the sections of DNA originally labeled "junk" because they served no identifiable function. The company's research suggests that parts of this "junk" DNA regulate protein production (and thus the onset and progression of disease) through genes that encode molecules known as microRNAs. Founded in 2000, Rosetta Genomics is exploring possible commercial applications of microRNA research to create a unique class of diagnostic and therapeutic products with an initial focus on various types of cancer, women's health ailments, and infectious diseases.
View the Comprehensive Company Description for Rosetta Genomics
The Company Description provides a historical perspective of Rosetta Genomics's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Rosetta Genomics's evolution in the marketplace.
